Medvarsity Logo
Cardiac arrhythmias and their treatment in critical care

CASE DISCUSSION

Cardiac arrhythmias and their treatment in critical care

India flagPresented India by Dr. Yogesh Rathod

Views

17,796

Case Description

In critical care, cardiac arrhythmias demand swift and precise intervention to prevent hemodynamic compromise. Treatment strategies include identifying and addressing underlying causes such as ischemia or electrolyte imbalances. Anti-arrhythmic medications may be administered, and in cases of...

Case Summary

  • Cardiac arrhythmias significantly impact patient outcomes in critical care, necessitating a clear understanding of their diagnosis and management. These arrhythmias are categorized as bradyarrhythmias (slow heart rate) and tachyarrhythmias (fast heart rate). Bradyarrhythmias include sinus bradycardia and varying degrees of AV blocks, while tachyarrhythmias encompass atrial fibrillation, atrial flutter, ventricular tachycardia, and supraventricular tachycardia.

Speaker Profile

Dr. Yogesh Rathod

Dr. Yogesh Rathod

Director & Consultant Critical Care Physician, Infectious Disease Specialist, ECMO & AI Clinician, Aadhar Group of Hospitals, Solapur
Dr. Yogesh Bhimrao Rathod is a consultant critical care physician with over 20 years of experience. He is currently the director and chairman of Aadhar Superspeciality Pvt. Ltd. and Aadhar Critical Care, both located in Solapur, Maharashtra, India.Dr. Rathod has a wealth of experience in all aspects of critical care, including critical care nephrology, cardiology, neurology, and gastroenterology. He is also proficient in anesthesiology, anesthesia procedures, pain management, interventionist intensive care, internal medicine, bronchoscopy, and thoracoscopy.In addition to his clinical practice, Dr. Rathod is also a researcher and educator

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.